APOE and cancer: Notably, in a prospective cohort study of 3,924 participants of the Framingham Heart Study Offspring cohort, Kulminski et al. observed that APOE4 was antagonistically associated with onsets of CVD and cancer, where APOE4 carriers were predisposed to an earlier onset of CVD and a delayed onset of cancer compared to the non-carriers11.